These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22711298)

  • 1. Biomarkers and surrogate endpoints in clinical trials.
    Fleming TR; Powers JH
    Stat Med; 2012 Nov; 31(25):2973-84. PubMed ID: 22711298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011-2018.
    Schuster Bruce C; Brhlikova P; Heath J; McGettigan P
    PLoS Med; 2019 Sep; 16(9):e1002873. PubMed ID: 31504034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases.
    Lonn E
    Pharmacoepidemiol Drug Saf; 2001; 10(6):497-508. PubMed ID: 11828831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.
    Medeiros FA
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO20-BIO26. PubMed ID: 28475699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate endpoints: a key concept in clinical epidemiology.
    Christensen R; Ciani O; Manyara AM; Taylor RS
    J Clin Epidemiol; 2024 Mar; 167():111242. PubMed ID: 38142762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
    Raghu G; Collard HR; Anstrom KJ; Flaherty KR; Fleming TR; King TE; Martinez FJ; Brown KK
    Am J Respir Crit Care Med; 2012 May; 185(10):1044-8. PubMed ID: 22505745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and surrogate endpoints in glaucoma clinical trials.
    Medeiros FA
    Br J Ophthalmol; 2015 May; 99(5):599-603. PubMed ID: 25034049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.
    Methy N; Bedenne L; Bonnetain F
    BMC Cancer; 2010 Jun; 10():277. PubMed ID: 20537166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.
    Powers JH
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):109S-123S. PubMed ID: 16305280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
    Raghu G; Ghazipura M; Fleming TR; Aronson KI; Behr J; Brown KK; Flaherty KR; Kazerooni EA; Maher TM; Richeldi L; Lasky JA; Swigris JJ; Busch R; Garrard L; Ahn DH; Li J; Puthawala K; Rodal G; Seymour S; Weir N; Danoff SK; Ettinger N; Goldin J; Glassberg MK; Kawano-Dourado L; Khalil N; Lancaster L; Lynch DA; Mageto Y; Noth I; Shore JE; Wijsenbeek M; Brown R; Grogan D; Ivey D; Golinska P; Karimi-Shah B; Martinez FJ
    Am J Respir Crit Care Med; 2024 Mar; 209(6):647-669. PubMed ID: 38174955
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs.
    Huang Y; Yuan J
    Expert Rev Clin Pharmacol; 2024; 17(5-6):477-487. PubMed ID: 38632893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011.
    Bikdeli B; Punnanithinont N; Akram Y; Lee I; Desai NR; Ross JS; Krumholz HM
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28325713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.
    De Gruttola VG; Clax P; DeMets DL; Downing GJ; Ellenberg SS; Friedman L; Gail MH; Prentice R; Wittes J; Zeger SL
    Control Clin Trials; 2001 Oct; 22(5):485-502. PubMed ID: 11578783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential surrogate endpoints in cancer research--some considerations and examples.
    Duffy SW; Treasure FP
    Pharm Stat; 2011; 10(1):34-9. PubMed ID: 20029937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force.
    Walton MK; Powers JH; Hobart J; Patrick D; Marquis P; Vamvakas S; Isaac M; Molsen E; Cano S; Burke LB;
    Value Health; 2015 Sep; 18(6):741-52. PubMed ID: 26409600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endpoints in respiratory diseases.
    de Benedictis FM; Guidi R; Carraro S; Baraldi E;
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():49-59. PubMed ID: 21104409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design issues and outcomes in IBD clinical trials.
    Sands BE; Abreu MT; Ferry GD; Griffiths AM; Hanauer SB; Isaacs KL; Lewis JD; Sandborn WJ; Steinhart AH
    Inflamm Bowel Dis; 2005 Nov; 11 Suppl 1():S22-8. PubMed ID: 16254479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for using potential surrogate endpoints in cancer screening trials.
    Webb AB; Berg CD; Castle PE; Crosby D; Etzioni R; Kessler LG; Menon U; Parmar M; Steele RJC; Sasieni PD
    Lancet Oncol; 2024 May; 25(5):e183-e192. PubMed ID: 38697164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The art and science of choosing efficacy endpoints for rare disease clinical trials.
    Cox GF
    Am J Med Genet A; 2018 Apr; 176(4):759-772. PubMed ID: 29423972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and composite study endpoints: separating the wheat from the chaff.
    Goldberg R; Gore JM; Barton B; Gurwitz J
    Am J Med; 2014 May; 127(5):379-84. PubMed ID: 24486289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.